Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001625101-19-000015
Filing Date
2019-04-01
Accepted
2019-04-01 16:10:59
Documents
2
Period of Report
2019-04-01
Effectiveness Date
2019-04-01

Document Format Files

Seq Description Document Type Size
1 DEF 14A plse-20190401xdef14a.htm DEF 14A 906022
2 GRAPHIC plse-20190401xdef14ag001.jpg GRAPHIC 6446
  Complete submission text file 0001625101-19-000015.txt   916181
Mailing Address 3957 POINT EDEN WAY HAYWARD CA 94545
Business Address 3957 POINT EDEN WAY HAYWARD CA 94545 510-906-4600
Pulse Biosciences, Inc. (Filer) CIK: 0001625101 (see all company filings)

EIN.: 465696597 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37744 | Film No.: 19720796
SIC: 3841 Surgical & Medical Instruments & Apparatus